Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002831779 | SCV003622529 | uncertain significance | Inborn genetic diseases | 2022-05-04 | criteria provided, single submitter | clinical testing | The c.2668G>A (p.V890M) alteration is located in exon 14 (coding exon 13) of the SPTBN2 gene. This alteration results from a G to A substitution at nucleotide position 2668, causing the valine (V) at amino acid position 890 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Breakthrough Genomics, |
RCV004695483 | SCV005190383 | uncertain significance | not provided | criteria provided, single submitter | not provided |